NVAX

Novavax (NVAX)

About Novavax (NVAX)

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Details

Daily high
$6.60
Daily low
$6.36
Price at open
--
52 Week High
$11.55
52 Week Low
$5.01
Market cap
1.1B
Dividend yield
0.00%
Volume
7
Avg. volume
3.4M
P/E ratio
3.72

Novavax News

Details

Daily high
$6.60
Daily low
$6.36
Price at open
--
52 Week High
$11.55
52 Week Low
$5.01
Market cap
1.1B
Dividend yield
0.00%
Volume
7
Avg. volume
3.4M
P/E ratio
3.72